Interoperability Platforms: Their Role in COVID-19 and Beyond

Interoperability Platforms: Their Role in COVID-19 and Beyond

Lyniate CEO Erkan Akyuz explains how interoperability platforms free up data exchange for patient care.

By themselves, the final Interoperability Rules from the ONC and CMS are landmark mandates for the healthcare industry. Their timing has coincided with a crippling pandemic, the likes of which haven’t occurred in recent memory. Together, these two game-changing events will force healthcare organizations to adopt technology and policies that allow providers, public health agencies, and epidemiological organizations to share data across the care continuum. Lyniate’s products enable this level of seamless data sharing.

What is an interoperability platform?

EA: Interoperability platforms like Lyniate’s Corepoint and Rhapsody allow players in the healthcare ecosystem to exchange data by creating interfaces between disparate systems. These interfaces could be between a health system’s EHR and its laboratory, billing, and radiology systems; a remote medical device and a provider’s EHR; or a provider and a public health system.

As patients increasingly demand access to their health data and serve as conduits for sharing it, our platforms will enable this type of data exchange as well.

What role do your platforms play in the COVID-19 pandemic?

EA: First, they allow providers and public health agencies to share, exchange, and report clinical data. Which patients have been tested? How are patients’ outcomes being monitored and tracked? Which providers have access to that data to ensure continuity of patient care? How is that data being reported to state and regional public health agencies, and, where appropriate, to the CDC?

Now we’re seeing a need to track inventory data — available beds, ventilators, and personal protective equipment. It’s important to collect this data in a central location so it can be allocated where there’s the greatest need.

With the increased stress on our health systems, inventory decisions must be made on a basis that optimizes their deployment. Currently, this data isn’t uniformly collected
in a central place. The COVID-19 pandemic will change this, and platforms like ours will be a vital layer in health systems’ IT infrastructure to enable efficient sharing of clinical and inventory data where ad hoc, stopgap measures are in place right now.


Read the full interview in this week's issue of Modern Healthcare.

Products | Services

Co-Creation Lab

About Lyniate

Knowledge Hub


Contact Support